All Money Raised Goes Directly to Pancreatic Cancer Research
|
|||
Swizz Beatz and Radio City Rockettes Performed to Support the Fight Against Pancreatic Cancer
The Madison Square Garden Company and AMC Networks Hosted Event at Tao Downtown in New York City
BETHPAGE, N.Y., Dec. 15, 2016 -- On Wednesday evening, December 14, The Madison Square Garden Company (NYSE:MSG) and AMC Networks (NASDAQ: AMCX) hosted the 16th Annual Holiday Rock & Roll Bash to benefit the Lustgarten Foundation, the nation’s largest private nonprofit funder of pancreatic cancer research. The Bash is the Foundation’s premier fundraising event, and this year, raised $1.2 million. Due to the support of private funding, 100 percent of every dollar raised goes directly to pancreatic cancer research.
Entertainment for the event, held at Tao Downtown in New York City, included a special DJ set from Grammy Award winning music producer and recording artist Swizz Beatz, along with an exclusive performance from the Christmas Spectacular by the world-famous Radio City Rockettes.
“The Holiday Rock & Roll Bash is one of the highlights of our year,” said Kerri Kaplan, president and chief executive officer of the Lustgarten Foundation. “Over the past 16 years, the Bash has raised more than $22 million for research. Our goal is to put an end to pancreatic cancer, and the only way to achieve this is through revolutionizing our understanding of this terrible disease. We know what needs to be done, and we have the leading researchers urgently working on earlier detection methods and more effective treatments.”
Pancreatic cancer is swift and silent, and often undetected until it is too late. The overall five-year survival rate for pancreatic cancer is eight percent and most with advanced cancer die within a year. There are no early detection tests, no effective long-term treatments and no cure. It is the third-leading cause of cancer deaths in the United States.
Since its inception, the Lustgarten Foundation has contributed more than $125 million toward pancreatic cancer research. Researchers are making great progress in the areas of early detection, improved therapies and personalized medicine.
The Lustgarten Foundation was established in 1998 to honor Marc Lustgarten, who served as the former vice chairman of Cablevision Systems Corporation and chairman of Madison Square Garden, before he died from pancreatic cancer. James Dolan, executive chairman of The Madison Square Garden Company and former chief executive officer of Cablevision; and Charles Dolan, executive chairman of AMC Networks and former chairman of Cablevision, helped establish the Foundation and have been closely involved in supporting its mission to advance pancreatic cancer research and paying homage to Mr. Lustgarten’s legacy.
Visit lustgarten.org to learn more about the Lustgarten Foundation’s fight to defeat pancreatic cancer.
About The Lustgarten Foundation
The Lustgarten Foundation is the largest private foundation dedicated to funding pancreatic cancer research. The Foundation supports research to find a cure for pancreatic cancer, facilitates dialogue within the medical and scientific community, and educates the public about the disease through awareness campaigns and fundraising events. Since its inception, the Foundation has directed $125 million to research and assembled the best scientific minds with the hope that one day, a cure can be found. Thanks to private funding, 100 percent of every dollar donated to the Foundation goes directly to pancreatic cancer research. For additional information, please visit www.lustgarten.org.
Contacts: Mikyl Cordova The Madison Square Garden Company 212-631-4337 [email protected]


Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 



